Neogen Chemicals Limited — Important, 01-02-2025: Financial Result Updates

For the quarter ended December 31, 2024, Neogen Chemicals Limited reported consolidated total income of ₹202.49 crore, representing a growth of approximately 22% year-over-year from ₹166.02 crore. This growth can be attributed to stronger demand for specialty chemicals as well as improved operational efficiencies following the recent amalgamation of its subsidiary, Buli Chemicals India Private Limited.

Net profit for the quarter stood at ₹10.01 crore compared to ₹1.06 crore in the same quarter last year, marking a significant increase. The Earnings Per Share (EPS) for the quarter is ₹3.80, substantially higher than the ₹0.41 recorded during the previous year. The increase in profitability is driven by lower operational costs and more favorable sales mix, aided by the merger, which also streamlined production processes.

Operational costs amounted to ₹187.32 crore, an increase from ₹160.41 crore year-over-year, driven largely by a rise in the cost of materials consumed and employee benefits, which demand scrutiny as the company scales up its operations.

The balance sheet appears healthy, with substantial equity growth bolstered by retained earnings. The company is strategically positioned to leverage its expanded operational scale and enhanced market presence following the merger. Market sentiment remains positive, with an expectation of continued growth fueled by strong demand trends in the specialty chemicals sector.

Investor insight suggests a **buy** stance, given the strong revenue and profit growth, effective cost management, and the favorable business outlook following strategic expansion via mergers. This positions Neogen Chemicals to capitalize on emerging opportunities in the specialty chemicals market.